Products
Synedgen has a robust development plan in progress across multiple indications utilizing its non-toxic, antibacterial platform. Lead Synedgen products are being developed to target drug resistant bacteria that grow in biofilms in the oral and nasal cavity, external wounds, lungs and gastrointestinal tract. These products are intended to control bacteria in challenging environments while enhancing the natural healing processes.
Four key lead indications are prioritized for near-term development:
- Regenasyn™ Treatment for Oral Mucositis
- Wound Irrigation Solution
- Antibacterial Burn and Wound Treatment
- Treatment for Infectious Sinusitis
Synedgen is also developing an environmental treatment to help control bacterial populations in health care environments.
- Surface Sanitizing Spray
Synedgen’s Pharmaceutical Manufacturing facility will consider proposals for contract manufacturing for processes that are aqueous based or require minimal hazardous waste.
Our expertise is in water-soluble polymer modification and purification. Please contact us for more information and to discuss your process.